Tetraphase Pharmaceuticals
| Region | Nordamerika |
| ISIN | US88165N1054 |
| Sektor | Biotechnologie |
| Website | https://www.tphase.com/ |
Tetraphase Pharmaceuticals is a clinical-stage life science company with a synthetic chemistry technology platform that has the potential to address the global health crisis caused by antibiotic resistance.
| Titel | Datum |
|---|---|
| DNV awards GASA approval to joint LCO2 carrier design by MOL, MISC, PETRONAS CCS Ventures and SDARI | vor 6 Tagen |
| MOL, MISC and PETRONAS form joint venture to advance cross-border CO2 transportation | vor ungefähr einem Monat |
| Petronas, MISC and MOL debut LCO2 carrier JV | vor ungefähr einem Monat |
| PETRONAS, MISC, MOL ink JV to Pioneer CO2 Transport | vor ungefähr einem Monat |
| Bursa, RHB, Hong Leong Bank, Axiata, MISC, IOI Properties, TM, GenP, Kerjaya Prospek, Sime Darby Property, 7-Eleven Malaysia, AAX, Pestec... | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Tesla (3 Artikel) | |
| Telit Communications (3 Artikel) | |
| The Naga Group (2 Artikel) | |
| The Priceline Group (2 Artikel) | |
| Alle anzeigen | |